Celonic is a Swiss-based 'Pure Play' biologics CDMO offering end-to-end drug substance development and manufacturing solutions for monoclonal antibodies, bispecifics, and other complex molecules. The company is a pioneer in next-generation bioprocessing technologies including process intensification and full perfusion. Celonic operates facilities in Basel, Switzerland and Heidelberg, Germany, and has a strategic alliance with CARBOGEN AMCIS for integrated ADC development and manufacturing.
Biologics CDMO, monoclonal antibodies, bispecific antibodies, ADC manufacturing, process intensification, perfusion bioprocessing, cell line development
2 sites worldwide
No reviews available yet.
No documents available.